België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bayer ag - suspensie concentraat (sc) - fluopyram 250 g/l (21,37 %) trifloxystrobine, 250 g/l (21,37 %)

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bayer ag - suspensieconcentraat (sc) - spirotetramat 100 g/l (9,3 % w/w)

Nederland - Nederlands - myHealthbox

bayer ag - olie dispersie - 30 g/l foramsulfuron 15 g/l cyprosulfamide 10 g/l thiencarbazon-methyl

Europese Unie - Nederlands - EMA (European Medicines Agency)

mylan ireland limited - rivaroxaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotische middelen - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Nederland - Nederlands - Adama

adama - difenoconazool - fungicide

Europese Unie - Nederlands - EMA (European Medicines Agency)

tmc pharma (eu) limited - fosdenopterin hydrobromide dihydrate - metal metabolism, inborn errors - andere maagdarmkanaal en metabolisme producten, - nulibry is indicated for the treatment of patients with molybdenum cofactor deficiency (mocd) type a.

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ge healthcare bv-srl - exametazime 0,5 mg - kit voor radiofarmaceutisch preparaat - 0,5 mg - exametazime 0.5 mg - technetium (99mtc) exametazime

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

mediam 85 rue nelson mandela 59120 loos (frankrijk) - tin(ii)fluoride - poeder voor oplossing voor injectie - natriumfluoride ; poloxameer ; stikstof (head space) (e 941), - technetium (99m tc) tin colloid

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

lantheus eu ltd. - bicisaatdihydrochloride 0,9 mg - kit voor radiofarmaceutisch preparaat - bicisaatdihydrochloride 0.9 mg - technetium (99mtc) bicisate

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ge healthcare bv-srl - tetrofosmine 0,23 mg - kit voor radiofarmaceutisch preparaat - 230 µg - tetrofosmine 0.23 mg - technetium (99mtc) tetrofosmin